These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 1725003

  • 1. Hypercholesterolemia modulates the effects of nitrendipine on blood pressure and platelet function in essential hypertension.
    Mazeaud MM, Sang KH, Astarie C, Levenson J, Simon A, Devynck MA.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S46-51. PubMed ID: 1725003
    [Abstract] [Full Text] [Related]

  • 2. Plasma lipids and platelet membrane fluidity in essential hypertension.
    Le Quan Sang KH, Mazeaud M, Astarie C, Duranthon V, Driss F, Devynck MA.
    Thromb Haemost; 1993 Jan 11; 69(1):70-6. PubMed ID: 8383361
    [Abstract] [Full Text] [Related]

  • 3. Hypercholesterolaemia alters platelet reactivity and the antihypertensive effect of nitrendipine.
    Le Quan Sang KH, Mazeaud M, Levenson J, Del Pino M, Pithois-Merli I, Simon A, Devynck MA.
    J Hypertens Suppl; 1991 Dec 11; 9(6):S410-1. PubMed ID: 1668012
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of hypertension induces a fall in platelet basal cytoplasmic calcium concentration without influencing platelet aggregation.
    Wilson J, Orchard MA, Prentice CR, Lees AD, Baig MW, Perrins EJ, Davies JA.
    Thromb Haemost; 1992 Dec 07; 68(6):683-6. PubMed ID: 1287883
    [Abstract] [Full Text] [Related]

  • 5. Blunted inhibition by insulin of agonist-stimulated calcium, pH and aggregatory responses in platelets from hypertensive patients.
    Touyz RM, Schiffrin EL.
    J Hypertens; 1994 Nov 07; 12(11):1255-63. PubMed ID: 7868873
    [Abstract] [Full Text] [Related]

  • 6. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 07; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 7. Platelet aggregation and in vivo shear forces.
    Mazeaud MM, Levenson J, Le Quan Sang KH, Simon A, Devynck MA.
    Thromb Haemost; 1994 Jan 07; 71(1):26-31. PubMed ID: 8165643
    [Abstract] [Full Text] [Related]

  • 8. Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients.
    Mazeaud MM, Driss F, Le Quan Sang KH, Duranthon V, Levenson J, Simon A, Devynck MA.
    Atherosclerosis; 1992 Jun 07; 94(2-3):201-11. PubMed ID: 1321632
    [Abstract] [Full Text] [Related]

  • 9. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R, Krishnan LK.
    Pathophysiol Haemost Thromb; 2007 Jun 07; 36(1):45-51. PubMed ID: 18332614
    [Abstract] [Full Text] [Related]

  • 10. Reduced platelet thromboxane formation after long-term administration of a dihydropyridine calcium channel blocker: a prospective, double-blind, placebo-controlled study with nitrendipine in borderline hypertensive patients with IDDM-type diabetes mellitus.
    Tschoepe D, Homberg M, Roesen P, Gries FA.
    Diabetes Res; 1992 Mar 07; 19(3):125-31. PubMed ID: 1286547
    [Abstract] [Full Text] [Related]

  • 11. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K, Löbel P, Steinhagen-Thiessen E.
    Eicosanoids; 1989 Mar 07; 2(1):39-45. PubMed ID: 2483819
    [Abstract] [Full Text] [Related]

  • 12. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P, Erne P, Hulthén UL, Ritz R, Kiowski W, Ji BH, Bühler FR.
    J Cardiovasc Pharmacol; 1984 Mar 07; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [Abstract] [Full Text] [Related]

  • 13. Serotonin metabolism and platelet aggregation under antihypertensive treatment with nitrendipine.
    Sebeková K, Raucinová M, Sedláková K, Dzúrik R.
    J Cardiovasc Pharmacol; 1988 Mar 07; 12 Suppl 4():S161-3. PubMed ID: 2468865
    [Abstract] [Full Text] [Related]

  • 14. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A, Lasaridis A, Settas L.
    J Cardiovasc Pharmacol; 1984 Mar 07; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [Abstract] [Full Text] [Related]

  • 15. Effect of calcium on blood pressure, platelet aggregation and erythrocyte sodium transport in Dahl salt-sensitive rats.
    Kang JS, Cregor MD, Smith JB.
    J Hypertens; 1990 Mar 07; 8(3):245-50. PubMed ID: 2159505
    [Abstract] [Full Text] [Related]

  • 16. Effects of nitrendipine and tiapamil on 45Ca2+ influx and on platelet aggregation.
    Kribben A, Fritschka E, Senger D, Sibold M, Distler A, Philipp T.
    J Cardiovasc Pharmacol; 1987 Mar 07; 10 Suppl 10():S68-9. PubMed ID: 2455144
    [Abstract] [Full Text] [Related]

  • 17. Antiplatelet effects of ticlopidine are reduced in experimental hypercholesterolemia.
    Hohlfeld T, Scharnowski F, Braun M, Schrör K.
    Thromb Haemost; 1994 Jan 07; 71(1):112-8. PubMed ID: 7513092
    [Abstract] [Full Text] [Related]

  • 18. [Essential hypertension and platelet cytosolic concentrations of H(+) and Ca2(+)].
    Astarie C, Levenson J, Simon A, Meyer P, Devynck MA.
    Arch Mal Coeur Vaiss; 1989 Jul 07; 82(7):1173-6. PubMed ID: 2510644
    [Abstract] [Full Text] [Related]

  • 19. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB, Bolli P, Erne P, Block LH, Kiowski W, Bühler FR.
    J Cardiovasc Pharmacol; 1984 Jul 07; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [Abstract] [Full Text] [Related]

  • 20. Alterations of cytosolic calcium in platelets and erythrocytes of Lyon hypertensive rats.
    Zicha J, Pernollet MG, Kunes J, Lacour B, Vincent M, Sassard J, Devynck MA.
    Am J Hypertens; 1995 Aug 07; 8(8):842-9. PubMed ID: 7576402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.